Recombinant and congenital genital malformation female Patient Reports March 22, 2010

Recombinant Side Effects Report #4675091-3
Recombinant side effect was reported by a Physician from on May 10, 2005. Female patient was diagnosed with in vitro fertilisation, luteal phase deficiency and was treated with Recombinant. After drug was administered, patient experienced the following side effects: apgar score low, blood gonadotrophin increased, blood pressure increased, caesarean section, congenital genital malformation female, foetal movements decreased, genitalia external ambiguous, gonadal dysgenesis, hermaphroditism. Recombinant dosage: unknown. During the same period patient was treated with MENOTROPINS, CETRORELIX, CHORIONIC GONADOTROPIN, ESTRADIOL, PROGESTERONE IN OIL. Patient was hospitalized. Patient recovered.